The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.


< Modified release formulations of a bupropion salt

> Diagnosis and treatment of human dormancy syndrome

> Quinazoline based EGFR inhibitors containing a zinc binding moiety

~ 00538